{"id": "ga4eoc", "title": "Xeris Pharmaceuticals (XERS). Volume is usually 600k but was double today.", "selftext": "Xeris Pharmaceuticals (XERS)\n\nPosted on r/RobinHoodPennyStocks but it didn\u2019t get much love. \n\nThis is a follow up to a [post](https://www.reddit.com/r/RobinHoodPennyStocks/comments/g4vxyz/xers_all_good_news/?utm_source=share&amp;amp;amp;amp;amp;amp;amp;amp;utm_medium=ios_app&amp;amp;amp;amp;amp;amp;amp;amp;utm_name=iossmf) I threw together on the side of the road. \n\nStock Price at last post: 1.85 - 8 days ago\n\nCurrently: 2.45\n\nWhat is [Xeris Pharmaceuticals](https://www.xerispharma.com)?\n\u201cXeris offers a novel formulation technology to bring ready-to-use, liquid-stable injectables to patients to remove many associated treatment burdens.\u201d\n\nWhat\u2019s in the pipeline?\n[They have](https://www.xerispharma.com/research-development/pipeline):\n\n1 approved\n\n1 in phase-3\n\n3 in phase-2\n\n1 in [phase-1](https://www.businesswire.com/news/home/20200420005197/en/) which was their most recent success story. \n\nWhy now?\n\nNext earnings call is 5/14/20. \n\nVolume [doubled](https://finance.yahoo.com/quote/XERS/) today. \n\nOn the earnings call, on 3/11/20, the CEO said \u201c2019 was a very busy and transformational year for Xeris. With our first product approved by the FDA in September 2019, we transitioned from being a development company to a commercial organization validating our novel XeriSol\u2122 formulation technology, while progressing several pipeline programs in the clinic.\u201d\n\n3/11/20 The company reported earnings of $1.86 million during the quarter, compared to analyst estimates of $0.76 million.\n\nHow did the stock do?\nIt went even lower. \n\nWhy? \n[Dow and Spy were falling on 3/11/20](https://finance.yahoo.com/amphtml/news/stock-market-news-live-updates-march-11-2020-115430808.html?guccounter=1&amp;amp;amp;amp;amp;amp;amp;amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&amp;amp;amp;amp;amp;amp;amp;amp;guce_referrer_sig=AQAAAJoz4qySwq6QQV0Srkl9ry8E1MvViWStLYNZkUQ4TzAENvhYYjMhsZikWPep__arz5fMfgAnIzLksakqdfC8fkQJbqZW4teMngOB_QKl1TcPF7JhT09Cu2w9S9pOgcAuQW314uWDrg5GFlSHbedYtm9gts8EU8ZLNcf0UARjEJDy) and little stocks with little cash on hand were liquidated by \u201cthe little guys\u201d. (A lot of \u201clittle\u201ds but I\u2019m leaving it.)\n\nI know nothing about anything but there is no way this stock is worth less than $4 at a minimum. \n\nMizuho Securities reiterated a \u201cbuy\u201d rating recently and believes it is worth [more.](https://www.tickerreport.com/banking-finance/5425685/svb-leerink-comments-on-xeris-pharmaceuticals-incs-q2-2020-earnings-nasdaqxers.html)\n\n[Institutional ownership ](https://imgur.com/gallery/smdAEyZ) has only increased since the start of 2020 with the most recent [purchase](https://imgur.com/gallery/0myWseg)  on 4/9/2020 of 505,317 shares. \n\nMy \u201cinvestment\u201d? \nI have 10 [options](https://imgur.com/gallery/xhB4m0U) ($0.74 average price) for 2.50 call on 10/16. \n\nAs always, do your own DD.", "created_utc": 1588142285.0, "permalink": "/r/wallstreetbets/comments/ga4eoc/xeris_pharmaceuticals_xers_volume_is_usually_600k/", "is_self": true}